Compare PED & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PED | GNTA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 34.0M |
| IPO Year | N/A | 2021 |
| Metric | PED | GNTA |
|---|---|---|
| Price | $0.55 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 159.3K | 92.8K |
| Earning Date | 11-17-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.43 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $33,244,999.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $305.89 | N/A |
| P/E Ratio | $5.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $1.28 |
| 52 Week High | $1.00 | $10.00 |
| Indicator | PED | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 36.07 |
| Support Level | $0.51 | $1.28 |
| Resistance Level | $0.57 | $1.68 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 44.81 | 27.42 |
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.